Nanogen's Nanocovax, a potential COVID-19 vaccine candidate in Vietnam, is entering human trials this week. With qualified researchers, state-of-the-art equipment, Nanogen's vaccine is under prompt development. Below are some insights into its manufacturing factory.

Nanogen’s COVID-19 vaccine Nanocovax is expected to be priced at no more than VND 500,000 (US $21.62) each dose and can be covered by health insurance.